E-LIB Suche - Ergebnisse für: Heymach, J.V.

1

Ramucirumab plus erlotinib versus placebo plus erlotinib in..:

Garon, E B ; Reck, M ; Nishio, K...
info:eu-repo/semantics/altIdentifier/pmid/37390764. , 2023

Link: https://hdl.handle.net/2..

2

Distinct tumor-infiltrating lymphocyte landscapes are assoc..:

Federico, L ; McGrail, D. J ; Bentebibel, S-E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019222/. , 2022

Link: http://www.ncbi.nlm.nih...

3

Major Pathologic Response and Prognostic Score Predict Surv..:

Pataer, A ; Weissferdt, A ; Correa, A.M...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jtocrr.2022.100420. , 2022

Link: https://serval.unil.ch/n..

4

Integrating cytokines and angiogenic factors and tumour bul..:

Zurita, A J ; Gagnon, R C ; Liu, Y...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558688/. , 2017

Link: http://www.ncbi.nlm.nih...

5

Circulating cytokines and monocyte subpopulations as biomar..:

Zurita, A J ; Khajavi, M ; Wu, H-K...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385961/. , 2015

Link: http://www.ncbi.nlm.nih...

6

EGFR biomarkers predict benefit from vandetanib in combinat..:

Heymach, J. V ; Lockwood, S. J ; Herbst, R. S..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...

7

Antitumour efficacy of MEK inhibitors in human lung cancer ..:

Morgillo, F ; Cascone, T ; D'Aiuto, E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172903. , 2011

Link: http://www.ncbi.nlm.nih...

8

Increased mobilisation of circulating endothelial progenito..:

Bhatt, R S ; Zurita, A J ; O'Neill, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137404. , 2011

Link: http://www.ncbi.nlm.nih...

9

A phase II pilot trial of low dose, continuous infusion, or..:

Bhatt, R.S ; Merchan, J ; Parker, R...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847062. , 2010

Link: http://www.ncbi.nlm.nih...

10

ZD6474 – clinical experience to date:

Heymach, J V
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362057. , 2005

Link: http://www.ncbi.nlm.nih...

11

Long-term actions of vector-derived nerve growth factor or ..:

Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32610, USA ( host institution ) ; Klein, R.L ; Muir, D.F...
Neuroscience. , 1999

Link: http://ufdc.ufl.edu/LS00..

12

Two conserved domains in the NGF propeptide are necessary a..:

Suter, U ; Heymach, J V ; Shooter, E M
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC452934. , 1991

Link: http://www.ncbi.nlm.nih...

13

Long-term actions of vector-derived nerve growth factor or ..:

Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL 32610, USA ( host institution ) ; Klein, R.L. ( author ) ; Muir, D.F. ( author )...
Neuroscience. , 1999

Link: https://doi.org/10.1016/..

14

IL-6 mediates suppression of T and NK cells function in EMT..:

Patel, Sonia A ; Nilsson, Monique B ; Yang, Yan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290888/. , 2023

Link: http://www.ncbi.nlm.nih...

15

Nivolumab and ipilimumab with concurrent stereotactic radio..:

Altan, Mehmet ; Wang, Yan ; Song, Juhee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335483/. , 2023

Link: http://www.ncbi.nlm.nih...